Modified Intraperitoneal Chemotherapy Without Bevacizumab as a First-Line Therapy for Newly Diagnosed Advanced Epithelial Ovarian Cancer-Two Centers Experiences
- Resource Type
- article
- Authors
- Yuanming Shen; Sangsang Tang; Junfen Xu; Xing Xie; Zhongbo Chen
- Source
- Frontiers in Medicine, Vol 9 (2022)
- Subject
- intraperitoneal chemotherapy
advanced epithelial ovarian cancer
first-line therapy
peritoneal metastasis
progression-free survival
Medicine (General)
R5-920
- Language
- English
- ISSN
- 2296-858X
ObjectivesTo evaluate whether the modified intraperitoneal plus intravenous chemotherapy regimen as a first-line therapy for advanced epithelial ovarian cancer (EOC) in China can be well-tolerated or confer any potential benefit on survival.MethodsWe evaluated the outcomes of women with newly diagnosed advanced-stage III-IV EOC treated with optimal cytoreductive surgery (